|
|
|
|
| LEADER |
03131nam a2200373 4500 |
| 001 |
on1111636855 |
| 003 |
OCoLC |
| 005 |
20200326101203.0 |
| 006 |
m o d |
| 007 |
cr mn|---auuua |
| 008 |
190802s2019 ne a o 000 0 eng |
| 040 |
|
|
|a AU@
|b eng
|e rda
|c AU@
|d OPELS
|d OCLCF
|d GrThAP
|
| 020 |
|
|
|a 9780128166680
|q (print)
|
| 035 |
|
|
|a (OCoLC)1111636855
|
| 050 |
|
4 |
|a RM315
|
| 082 |
0 |
4 |
|a 615.7/8
|2 23
|
| 245 |
0 |
0 |
|a Neuropsychotherapeutics /
|c edited by Jeffrey M. Witkin.
|
| 250 |
|
|
|a First edition.
|
| 264 |
|
1 |
|a Amsterdam, The Netherlands :
|b Elsevier Academic Press,
|c 2019.
|
| 264 |
|
4 |
|c Ã2019.
|
| 300 |
|
|
|a 1 online resource (312 pages) :
|b chiefly colour illustrations.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in pharmacology,
|x 1054-3589 ;
|v v. 86
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 505 |
0 |
|
|a Preface / Jeffrey M. Witkin -- GPCR drug discovery-moving beyond the orthosteric to the allosteric domain / Christian C. Felder -- Lipid rafts in psychiatry / Nathan H. Wray and Mark M. Rasenick -- Rapid-acting antidepressants / Jeffrey M. Witkin, Anna E. Martin, Lalit K. Golani, Nina Z. Xu and Jodi L. Smith -- mGlu2/3 receptor antagonists / Shigeyuki Chaki -- Nitric oxide: antidepressant mechanisms and inflammation / Mehdi Ghasemi -- Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders / Laura B. Teal, Robert W. Gould, Andrew S. Felts and Carrie K. Jones -- Medications development for food-based and drug use disorders / Fernando B. de Moura, Stephen J. Kohut and Jack Bergman -- Obsessive compulsive disorder (OCD): current treatments and a framework for neurotherapeutic research / Erik Z. Woody, Kurt Leroy Hoffman and Henry Szechtman -- Positive allosteric modulators of the dopamine D1 receptor: a new mechanism for the treatment of neuropsychiatric disorders / Kjell A. Svensson, Junliang Hao and Robert F. Bruns.
|
| 520 |
|
|
|a Neuropsychotherapeutics, Volume 86, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field, with this updated edition including sections on Pharmacotherapy of psychiatric disorders, Allosteric mechanisms for neuropsychopharmacology, Lipid rafts, Rapid-acting antidepressants, mGlu2/3 receptor antagonists, Nitric oxide: antidepressant mechanisms and inflammation, Anxiety disorders, mGlu receptors and schizophrenia, mAChR ligands for schizophrenia and addiction, PDE10 inhibitors, Obsessive-compulsive disorder, Addiction disorders (including eating), Dopamine D1 PAMs as a New Mode for Treatment of Neuropsychiatric Disorders, and more.
|
| 650 |
|
0 |
|a Neuropsychopharmacology.
|
| 650 |
|
7 |
|a Neuropsychopharmacology.
|2 fast
|0 (OCoLC)fst01036504
|
| 655 |
|
4 |
|a Electronic books
|
| 700 |
1 |
|
|a Witkin, Jeffrey M.,
|e editor.
|
| 830 |
|
0 |
|a Advances in pharmacology (San Diego, Calif.) ;
|v 86.
|
| 856 |
4 |
0 |
|3 ScienceDirect
|u https://www.sciencedirect.com/science/bookseries/10543589/86
|z Full Text via HEAL-Link
|
